Ethyl 2-((2-ethoxyphenyl)amino)-2-oxoacetate, 97%, 10g

3-cyclopentyl-3-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazol-1-yl]propanenitrile, 97.0%, 100mg

6-METHYLTHIENO[2,3-D]PYRIMIDIN-4-AMINE, 95.0%, 1g

2,2-Dibromo-1,1-binaphthyl, 96.0%, 1g

Centrifuge filter unit Ultrafree-CL, hydrophilic PTFE membrane, sample volume up to 2.0 ml, 0,45 µm, 25 Piece(s)

tert-Butyl 7-formyl-8-hydroxy-2,3-dihydrobenzo[f][1,4]oxazepine-4(5H)-carboxylate, 97%, 100mg

2-(9H-Fluoren-2-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)(T)5g

Methyl 6-chloro-1H-pyrrolo[2,3-b]pyridine-2-carboxylate, 95.0%, 1g

2-Dodecylphenol>98.0%(GC)25g

[(5-ethyl-1,3,4-oxadiazol-2-yl)thio]acetic acid hydrate, 95.0%, 1g

N-Benzyl-1,3-propanediamine>96.0%(GC)(T)5mL

(2S)-1-(BENZYLOXY)-2-METHYL-3-PENTANONE, 95.0%, 250mg

3-Amino-1,2-propanediol>98.0%(GC)(T)25g